Price T Rowe Associates Inc Amneal Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 130,649 shares of AMRX stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130,649
Previous 126,676
3.14%
Holding current value
$1.36 Million
Previous $1.06 Million
0.47%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
144MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$183 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$128 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$122 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$117 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$58.5 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.57B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...